David B. Reitz

2.0k citations

42 papers · 1.5k indexed · h-index 21

Organic Chemistry top 2%
- Synthesis and biological activity 9
- Coordination Chemistry and Organometallics 9
- Synthesis of β-Lactam Compounds 7
- Chemical Synthesis and Reactions 4
Pharmacology top 5%
- Inflammatory mediators and NSAID effects 10
Pharmaceutical Science top 5%
Molecular Biology
- Chemical Synthesis and Analysis 7
- Receptor Mechanisms and Signaling 4
Biochemistry top 10%
Genetics
- Estrogen and related hormone effects 5

Co-authors: Peter Beak Peter C. Isakson H. T. Huang Carol M. Koboldt Emily J. Reinhard Matthew Mahoney William F. Vernier Marvin J. Meyers
Cited by: Organic Chemistry Pharmacology Pharmaceutical Science
Journals: Bioorganic & Medicinal Chemistry Letters (10 papers)Journal of Medicinal Chemistry (7 papers)The Journal of Organic Chemistry (5 papers)
Partner nations: United States

In The Last Decade

David B. Reitz

42 papers receiving 1.4k citations

Peers

Countries citing papers authored by David B. Reitz

Since Specialization

Citations

This map shows the geographic impact of David B. Reitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Reitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Reitz more than expected).

Fields of papers citing papers by David B. Reitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Reitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Reitz. The network helps show where David B. Reitz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David B. Reitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David B. Reitz Line = papers co-authored together David B. Reitz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy Journal of Medicinal Chemistry ·Marvin J. Meyers,A. C. Upton,Susan L. Hockerman,Xiangyang Chen,Scott A. Long,Matthew Mahoney,E. Rancatore,Danny J. Garland,James R. Blinn,Joe Collins,Shengtian Yang,H. T. Huang,Kevin F. McGee,Jay M. Wendling,Jessica D. Dietz,Maria Payne,Bruce L. Homer,Marcia I. Heron,David B. Reitz,Xiao Hu	2010	77
2	Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2) Bioorganic & Medicinal Chemistry Letters ·John I. Trujillo,Marvin J. Meyers,David R. Anderson,Shridhar G. Hegde,Matthew Mahoney,William F. Vernier,J B Lagrange,Kun Wu,Vivien Renauld,Peter Morrens,David B. Reitz	2007	130
3	Design, synthesis, and biological evaluation of pyrazinones containing novel P1 needles as inhibitors of TF/VIIa Bioorganic & Medicinal Chemistry Letters ·John I. Trujillo,H. T. Huang,William L. Neumann,Matthew Mahoney,Scott A. Long,Wei Huang,Danny J. Garland,Ning Le-wei,Zaheer Abbas,Michael S. South,David B. Reitz	2007	16
4	A novel class of apical sodium co-dependent bile acid transporter inhibitors: The 1,2-Benzothiazepines Bioorganic & Medicinal Chemistry Letters ·Michael B. Tollefson,Stephen A. Kolodziej,Theresa Fletcher,William F. Vernier,Célia Barrena Gonzalez,Bradley T. Keller,David B. Reitz	2003	28
5	A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 2,3-disubstituted-4-phenylquinolines Bioorganic & Medicinal Chemistry Letters ·Michael B. Tollefson,William F. Vernier,H. T. Huang,Sandra Gödden,Emily J. Reinhard,Célia Barrena Gonzalez,Bradley T. Keller,David B. Reitz	2000	13
6	ChemInform Abstract: 1,2‐Diarylcyclopentenes as Selective Cyclooxygenase‐2 Inhibitors and Orally Active anti‐Inflammatory Agents. ChemInform ·Yu . V. Maystrov,Graham Anderson,Earl G. Burton,J. Nita Cogburn,Joe Collins,Daniel J. Garland,S A Gregory,Hechang Huang,Peter C. Isakson,Carol M. Koboldt,Eugene W. Logusch,M. E. Morales-Anduaga,William E. Perkins,Emily J. Reinhard,Karen Seibert,Amy W. Veenhuizen,荒井一彦,David B. Reitz	1996	4
7	Novel 1,2-diarylcyclopentenes are selective, potent, and orally active cyclooxygenase inhibitors Medicinal Chemistry Research ·David B. Reitz,James J. Li,J.G. Turcott,Emily J. Reinhard,Bon Kweon Koo,Florian Schiefer,Joe Collins,Danny J. Garland,Karen Seibert,Carol M. Koboldt,Susan A. Gregory,Amy W. Veenhuizen,Yan Zhang,Peter C. Isakson	1995	10
8	Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629. Molecular Pharmacology ·Gillian M. Olins,Artem Oganov,Ellen G. McMahon,Maria A. Palomo,David B. Reitz	1995	17
9	Cyclooxygenase-2 Inhibitors Current Pharmaceutical Design ·David B. Reitz,Peter C. Isakson	1995	28
10	ChemInform Abstract: Selective Cyclooxygenase Inhibitors: Novel 4‐Spiro 1,2‐ Diarylcyclopentenes are Potent and Orally Active COX‐2 Inhibitors. ChemInform ·David B. Reitz,Hechang Huang,Plato Js,Daniel J. Garland,R. Manning,Graham Anderson,S A Gregory,Carol M. Koboldt,William E. Perkins,Karen Seibert,Peter C. Isakson	1995	1
11	A novel one-pot conversion of methyl sulfones to sulfonamides Tetrahedron Letters ·H. T. Huang,Emily J. Reinhard,David B. Reitz	1994	17
12	Selective Cyclooxygenase Inhibitors: Novel 1,2-Diarylcyclopentenes Are Potent and Orally Active COX-2 Inhibitors Journal of Medicinal Chemistry ·David B. Reitz,James J. Li,J.G. Turcott,Emily J. Reinhard,Joe Collins,Gary D. Anderson,Susan A. Gregory,Carol M. Koboldt,William E. Perkins	1994	96
13	Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists Journal of Medicinal Chemistry ·Bon Kweon Koo,David B. Reitz,Tian yu Liu,Gillian M. Olins,T E Ekwere,Ellen G. McMahon,Maria A. Palomo,J P Koepke,Glenn J. Smits	1993	20
14	In Vivo Pharmacology of SC-51316, a Nonpeptidic Angiotensin II Receptor Antagonist American Journal of Hypertension ·Gillian M. Olins,Glenn J. Smits,J P Koepke,Hechang Huang,David B. Reitz,R. Manning,J Talegaonkar	1993	5
15	Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists Journal of Medicinal Chemistry ·Philippe R. Bovy,David B. Reitz,Joseph T. Collins,Tian yu Liu,Gillian M. Olins,T E Ekwere,Ellen G. McMahon,Maria A. Palomo,J P Koepke,Sandra Pérez García,Ludovico Vecchione,Jeffrey F. Gaw	1993	34
16	In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316. Journal of Pharmacology and Experimental Therapeutics ·Gillian M. Olins,T E Ekwere,Ellen G. McMahon,Maria A. Palomo,J R Schuh,Delores J. Blehm,Hui‐Chun Huang,David B. Reitz,R. Manning,Edward H. Blaine	1992	21
17	A directed metalation of N-tert-butyl-N-methyl-2-methoxybenzamide. Short syntheses of 2-methoxy-6-methylbenzoic acid and lunularic acid The Journal of Organic Chemistry ·David B. Reitz,Steven M. Massey	1990	27
18	Metalation and electrophilic substitution of amine derivatives adjacent to nitrogen: .alpha.-metallo amine synthetic equivalents Chemical Reviews ·Peter Beak,杜建东,David B. Reitz	1984	216
19	Dipole-stabilized carbanions: secondary (.alpha.-lithioalkyl)alkylamine synthetic equivalents from N,N-dialkyl-2,2-diethylbutyramides The Journal of Organic Chemistry ·David B. Reitz,Peter Beak,Anthony Tse	1981	17
20	Dipole-stabilized carbanions from thioesters. Evidence for stabilization by the carbonyl group Journal of the American Chemical Society ·David B. Reitz,Peter Beak,Vik Arora,Larry S. Helmick	1978	16

About David B. Reitz

David B. Reitz is a scholar working on Organic Chemistry, Pharmacology and Pharmaceutical Science, having authored 42 papers that have together received 1.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Synthesis and biological activity (9 papers), Coordination Chemistry and Organometallics (9 papers), Chemical Synthesis and Analysis (7 papers), Synthesis of β-Lactam Compounds (7 papers), Estrogen and related hormone effects (5 papers), Receptor Mechanisms and Signaling (4 papers) and Chemical Synthesis and Reactions (4 papers). The work is most often cited by research in Organic Chemistry (1.1k citations), Pharmacology (293 citations) and Pharmaceutical Science (97 citations). David B. Reitz has collaborated with scholars based in United States. Frequent co-authors include Peter Beak, Peter C. Isakson, H. T. Huang, Carol M. Koboldt, Emily J. Reinhard, Matthew Mahoney, William F. Vernier, Marvin J. Meyers, James J. Li and David R. Anderson. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Tetrahedron Letters and Chemical Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact